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Damage caused to neural tissue by disease or injury frequently produces a
discontinuity in the nervous system (NS). Such damage generates diverse alterations
that are commonly permanent, due to the limited regeneration capacity of the
adult NS, particularly the Central Nervous System (CNS). The cellular reaction
to noxious stimulus leads to several events such as the formation of glial and
fibrous scars, which inhibit axonal regeneration in both the CNS and the Peripheral
Nervous System (PNS). Although in the PNS there is some degree of nerve
regeneration, it is common that the growing axons reinnervate incorrect areas,
causing mismatches. Providing a permissive substrate for axonal regeneration in
combination with delivery systems for the release of molecules, which enhances
axonal growth, could increase regeneration and the recovery of functions in the
CNS or the PNS. Currently, there are no effective vehicles to supply growth
factors or cells to the damaged/diseased NS. Hydrogels are polymers that are
biodegradable, biocompatible and have the capacity to deliver a large range of
molecules in situ. The inclusion of cultured neural cells into hydrogels forming
three-dimensional structures allows the formation of synapses and neuronal survival.
There is also evidence showing that hydrogels constitute an amenable substrate for
axonal growth of endogenous or grafted cells, overcoming the presence of axonal
regeneration inhibitory molecules, in both the CNS and PNS. Recent experiments
suggest that hydrogels can carry and deliver several proteins relevant for improving
neuronal survival and axonal growth. Although the use of hydrogels is appealing, its
effectiveness is still a matter of discussion, and more results are needed to achieve
consistent recovery using different parameters. This review also discusses areas of
opportunity where hydrogels can be applied, in order to promote axonal regeneration of
the NS.
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INTRODUCTION
The nervous system (NS) is responsible for the interaction
between organisms and their environment; it confers the ability
to respond to external stimuli. However, when an injury
occurs in this system, such ability is impaired. Understanding
fundamental mechanisms involved in the response to damage
might be used to design therapeutic interventions aimed to
promote functional recovery. Axonal regeneration capacity is
very limited in the Central Nervous System (CNS; Gurgo et al.,
2002; Case and Tessier-Lavigne, 2005). Although the Peripheral
Nervous System (PNS) is able to grow axons after a nerve
injury, the lost function is not always restored, because the
regenerated axons are unable to reinnervate areas previously
connected by them (Johnson et al., 2005). This review describes
first the elements that impede axonal regeneration following
injury in CNS and PNS, and later discuss how hydrogels might
attenuate the inhibitory elements for axonal regeneration in both
systems.
NERVOUS SYSTEM RESPONSE TO INJURY AND ITS ROLE IN
AXONAL GROWTH INHIBITION
An injury in the NS could imply a loss of tissue, interrupted
communication caused by damage of synaptic contacts or
disrupted information flow between cell soma and axons.
Different events occur after NS damage, depending on several
factors, such as the type of injury. Many of these events
are responsible for the inhibitory environment during axonal
regeneration. We next describe the differential responses to lesion
of CNS and PNS.
CNS
Glial and fibrous scar formation
The disruption of the blood brain barrier (BBB) after damage
allows the infiltration of blood proteins to the CNS, which
triggers an inflammatory reaction (Kawano et al., 2012). White
cells and macrophages enter through the lesion site and migrate
to the surrounding neural tissue, releasing various cytokines
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and chemokines (Merrill and Benveniste, 1996; Donnelly
and Popovich, 2008). These events lead to the activation
of astrocytes, microglia and oligodendrocyte progenitor cells,
to form the glial scar around the lesion site (Shearer and
Fawcett, 2001; Kawano et al., 2012; Figure 1A). These activated
cells release different molecules involved in inflammation, BBB
restoration and neuroprotection (Yiu and He, 2006; Rolls
et al., 2009). Glial scar isolates the damage area from adjacent
tissue (Figure 1A); this contributes to maintaining homeostatic
functions as ion and fluids balances, production of pro- and
anti-inflammatory molecules, secretion of growth factors and
free radicals elimination (Yiu and He, 2006; Rolls et al., 2009).
In addition, a fibrotic scar (Figure 1A), which is produced
by the intrusion of fibroblasts from the damaged meninges
and that release extracellular matrix (ECM) proteins such
as type IV Collagen, Fibronectin and Laminin, also forms
around the site of lesion (Kawano et al., 2012). Moreover,
fibroblasts and astrocytes cooperate to establish a continuous
basal lamina around the glial scar (Mathewson and Berry,
1985; Shearer and Fawcett, 2001). The barrier formed by
the glial and fibrous scars helps to contain the damage,
preventing it from spreading and affecting surrounding tissue.
The functions of these barriers are not fully understood yet,
but their inhibitory effect on axonal growth has been extensively
documented (Fawcett and Asher, 1999; Sandvig et al., 2004;
Silver and Miller, 2004; Yiu and He, 2006; Fitch and Silver,
2008).
Inhibitory elements for axonal growth
Various elements have been described as being responsible of the
adverse environment for axonal growth. The glial scar constitutes
a physical barrier that impedes passage of axons across the lesion
site (Figure 1A). In addition, the activated glial cells in the
scar secrete ECM components, especially chondroitin sulphate
proteoglycans (CSPGs) such as Neurocan, Brevican, Versican and
NG2 (Fawcett and Asher, 1999; Tang et al., 2003), which exert
an inhibitory influence on axonal growth (Shearer and Fawcett,
2001; Tang et al., 2003; Silver and Miller, 2004). Activation of
Rho small GTPase proteins which are recognized by CSPGs
blocks actin polymerization in growing neurites (Sandvig et al.,
2004; Díaz-Martínez and Velasco, 2009). Some of the inhibitory
molecules over-expressed in the site of lesion are Myelin-
associated glycoprotein, Oligodendrocyte-myelin glycoprotein,
Nogo protein and its receptor Nogo-66, Semaphorin 4D, Ephrin
B3 (Kawano et al., 2012), Semaphorin 3D (Pasterkamp et al.,
1999) and Ephrin B2 (Bundesen et al., 2003). The lesion site has
been shown to secrete chemo-repulsive molecules like Tenascin
(McKeon et al., 1991) and Semaphorin 3A (Pasterkamp et al.,
1999). The fibrotic scar also produces inhibitory elements: it has
been reported that fibroblasts express NG2 proteoglycan (Tang
et al., 2003), Phosphocan (Tang et al., 2003), Tenascin-C (Tang
et al., 2003), Semaphorin 3A (Pasterkamp et al., 1999) and Ephrin
B2 (Bundesen et al., 2003). These data indicate that glial and
fibrous scars contribute to the low rate of axonal regeneration.
One option to bypass these inhibitory effects would be to prevent
scar formation, but this could imply secondary effects, such as
spreading of the damage. Alternatively, a modification of the
lesion environment by introducing a device that is a permissive
for axonal growth is feasible.
PNS
The damage produce diverse signals that indicate the neuronal
cell to either go into regeneration processes or to undergo
programmed cell death (Maripuu et al., 2012). Ca2+ entry
(Maripuu et al., 2012) and the interruption of the retrograde
transport system are the initial signals of neuronal damage
(Dahlin, 2008). Damage to axons also release growth factors such
as Ciliary Neurotrophic Factor, Leukemia Inhibitory Factor and
Interleukin-6 in the site of injury (Hanz and Fainzilber, 2006;
Raivich and Makwana, 2007). After a peripheral axon is cut or
crushed, the distal part of the severed axon suffers a degenerative
processes (Figure 2A) termed Wallerian degeneration (Mietto
et al., 2008; Freeman, 2014), that consists in the degradation
of axonal organelles and proteins, and disintegration of axonal
structures (Mietto et al., 2008). In order to obtain successful
axon regeneration, activation and proliferation of Schwann cells
(SC) are needed (Dahlin, 2008). SC and macrophages phagocyte
the disrupted myelin sheath and cell debris (Figure 2A) to
clear the zone (Johnson et al., 2005). In addition, SC have
been shown to provide a favorable substrate for regenerating
axons (Maripuu et al., 2012). As a part of the regenerative
processes, several axon growth cones emerge from the proximal
stump (Figure 2A) and their growth is guided by Bugner
bands, which are SC apposed around the basement membrane
(Valls-Sole et al., 2011). Basement membrane is constituted
by ECM proteins such as Laminin and contributes to the
adhesion and guidance of cells during development (Silver
and Miller, 2004). These emerging sprouts grow to reach
the distal stump across the site of lesion. However, because
the adverse environment, most of these developments disperse
in various directions and become abortive (Johnson et al.,
2005; Valls-Sole et al., 2011; Figure 2A). The few sprouts that
successfully reach the distal stump grow in close apposition
with SC (Johnson et al., 2005). To complete this processes, the
regenerated axon is myelinated by SC to produce junctional
nodes of Ranvier and internodal Schmidt-Lanterman incisures
(Johnson et al., 2005). After the regeneration process, SC
release Nerve Growth Factor (NGF) and Glial cell-Derived
Neurotrophic Factor (GDNF) in the regenerated site (Maripuu
et al., 2012).
Elements involved in the axonal regeneration process in the clinic
Although the PNS has some regeneration capacity, functional
restoration is not always achieved (Hill et al., 2011; Valls-Sole
et al., 2011). Factors involved in the recovery are age (Lundborg
and Rosén, 2001; Ruijs et al., 2005), the period of time between
injury and medical assistance (Ruijs et al., 2005), the type of nerve
that is damaged and the magnitude of injury (Lundborg, 2004);
for example, when the lesion consists in a moderate compression,
the chances of regeneration are higher (Lundborg, 2004) than
when the axon has been transected (Maripuu et al., 2012). Current
treatments trying to reconnect the severed nerve offer a low
success rate. One major problem in these surgical procedures is
that axons do not innervate the correct area, since many axons
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FIGURE 1 | Hydrogel promotes axonal regeneration after Traumatic
Brain Injury (TBI). (A) After a TBI, which causes axonal degeneration,
inhibitory elements for axonal regeneration such as the formation of a
cavity in the tissue, fibrotic and glial scars and reactive astroglia, are
present. (B) When the newly formed cavity is filled with hydrogel, it
provides a suitable substrate for axonal growth, in addition to the
possibility to be combined with molecules that are released from
hydrogel to enhance regeneration.
compete to connect and this lead to loss of selectivity (Valls-
Sole et al., 2011). These mismatches could convey disturbances in
signaling between CNS neurons and PNS neurons, which result
in sensorimotor alterations (Valls-Sole et al., 2011). Although
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FIGURE 2 | Hydrogels promotes axonal regeneration after a
peripheral nerve lesion. (A) After a lesion where peripheral nerves are
severed, inhibitory elements for axonal regeneration arise either in
proximal or distal segments. Although there can be regeneration to unite
both stumps, it is common that mismatches are formed. (B) When the
lesion area is connected with a rigid tubular structure and this is filled with
a hydrogel, there is a mechanical support and a suitable substrate for
axonal growth. In addition, the hydrogel can serve as a carrier of
molecules that promote axonal regeneration and ultimately functional
recovery.
PNS has more permissive environment in contrast to CNS, the
majority of regeneration processes do not reach to innervate
the pre-lesional area (Figure 2A), which leads to several adverse
consequences.
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SCAFFOLDS THAT PROMOTE AND GUIDE AXONAL GROWTH
BIOMATERIALS
Biomaterials possess properties that make them biocompatible,
meaning that they do not produce cytotoxic or immunologic
reactions; their components should be susceptible to modifi-
cations, and the process of its production ideally should be easy
and reliable (Holmes, 2002). It is important to mention that
the specific requirements will dictate the origin of biomaterials.
Natural biomaterials such as collagen matrix mimic largely the
extracellular environment. However, natural materials present
disadvantages such as lot variability (Zhang et al., 2005b),
the generation of immune reactions and they may contain
pathogenic agents (Holmes, 2002). On the other hand, synthetic
materials can have a more consistent quality control but are
not always compatible with host tissue (Metcalfe and Ferguson,
2007). Other advantages of synthetic materials are that they
are free of pathogenic agents (Holmes, 2002) and could be
readily modified in order to elicit a tissue response, for example,
it is possible to add the isoleucine-lysine-valine-alanine-valine
(IKVAV) motif which enhances cellular adhesion (Cheng et al.,
2013).
SCAFFOLDS
The purpose of implanting a biomaterial in a tissue is to provide
suitable physical support to cells in order to achieve regeneration.
This substrate should mimic as much as possible the natural
matrix, so it should constitute a three-dimensional (3D) structure
with porous size that allows the exchange of nutrients and oxygen
(Hollister, 2005; Zhang et al., 2005b). Furthermore, it needs to
provide a substrate for cellular adhesion, and in selected cases,
could promote guided growth, proliferation, differentiation or
apoptosis by scaffold-cell or by cell-cell interactions (Hollister,
2005; Zhang et al., 2005a). Some scaffolds such as hydrogels, as
we will see later, have the ability to deliver several components.
Therefore, the scaffold is a dynamic element that might play an
important role in the regenerative process.
EARLY ATTEMPTS TO PROMOTE AXONAL REGENERATIONS USING
SCAFFOLDS
The first studies, aimed to promote axonal growth after injury,
were performed in the PNS using rigid materials. These attempts
mainly used tubular structures to protect and guide the growth
of regenerating axons. However, the used materials were not
biocompatible, such as silicone conduits (Cheng and Lin, 2004),
mini guide channels of a polyacrylonitrile:polyvinylchloride co-
polymer (Bamber et al., 1999), polytetrafluoroethylene and
collagen conduits (Vasconcelos and Gay-Escoda, 2000), guidance
channels of polyvinylidene fluoride (Aebischer et al., 1987),
cylinders made of poly (D,L-lactic-co-glycolic acid) (Gautier
et al., 1998) and poly (D,L-lactic acid) macroporous guidance
scaffolds (Patist et al., 2004). Although in some cases a partial
axonal regeneration was achieved, most of them did not induce
successful regeneration, even after addition of trophic factors.
These materials did not possess the required properties to
support cell attachment, axonal growth, and some of them
even induced an immune reaction. Although many biomaterials,
natural or synthetic, have been proved to posses some of
these properties, currently there is not a consistent strategy to
induce a complete axonal regeneration either in the CNS or in
the PNS.
SYNTHESIS AND DEGRADATION OF HYDROGELS
POLYMERIZATION
Hydrogels are hydrophilic polymers that can incorporate up to
90% of its dry weight of water in its structure (Aurand et al.,
2012; Hoffman, 2012). Water incorporation occurs during the
gelling process, in which a liquid polymer solution turns into
a gel structure, by polymerization of monomers (Aurand et al.,
2012). Gelling involves the formation of cross-links in response
to different stimuli (Sawheny et al., 1993; Aurand et al., 2012).
The density of a gel can be modified, and the change in stiffness
or porosity impact on the interaction of gels with cells (Lee and
Mooney, 2001; Aurand et al., 2012; Kirschner and Anseth, 2013).
Several stimuli trigger the polymerization of hydrogels:
temperature (He et al., 2000; Jeong et al., 2000; Tate et al.,
2001), pH (Srividya et al., 2001; Cheng et al., 2009; Chiu et al.,
2009), UV light exposure (Sawheny et al., 1993; Mellott et al.,
2001; Bryant and Anseth, 2002; Chatterjee et al., 2010), or
ionic concentration (Ellis-Behnke et al., 2006; Nagai et al., 2006;
Koutsopoulos and Zhang, 2012, 2013). The formation of gels
in situ in living tissue limits the use of UV light, extreme pH
or non-physiological temperatures. Therefore, many hydrogels
have been devised to initiate the gelling process when in contact
with physiological temperature (Jeong et al., 2000; Tate et al.,
2001), ionic concentration (Ellis-Behnke et al., 2006; Nagai et al.,
2006; Koutsopoulos and Zhang, 2012, 2013) or pH (Srividya
et al., 2001; Chiu et al., 2009). The in situ gelling process of
hydrogels is unique, because the resulting polymer can take the
form of the receiving tissue. This is particularly important for
some lesions of the NS, in which an irregular cavity is formed
and this discontinuity impedes axonal regeneration as described
previously. Hydrogels can fill completely the space, whereas pre-
formed structures are not suitable for this application (Macaya
and Spector, 2012).
DEGRADATION
Degradation of hydrogels occurs by breaking of covalent bonds
(Aurand et al., 2012). Several factors influence the rate of
degradation. Water access is one of them: it has been shown that
when hydrogels are exposed to in vitro conditions, hydrolysis
is the main reason of bond disruption due to high availability
of water; in contrast, when hydrogels are in in vivo conditions,
enzymatic activity, in particular metalloproteases, is the principal
cause of degradation (Lutolf et al., 2003; Patterson and Hubbell,
2010). Properties of hydrogel also influence this process: in high-
bond density hydrogels the disruption begins from the surface, in
contrast to low-bond density hydrogel, where it begins from the
interior of the structure, due to the ability of water or enzymes to
penetrate the hydrogel (von Burkersroda et al., 2002).
HYDROGELS AS DELIVERY SYSTEMS
Hydrogels have properties that could make them a good
alternative as a drug release system. During the gelling process
it is possible to incorporate different types of molecules or cells
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into the gel structure (Nagai et al., 2006; Kobsa and Saltzman,
2008; Censi et al., 2012; Koutsopoulos and Zhang, 2012). The
incorporation of molecules into hydrogel is facilitated by the high
quantity of water that permits the uptake and diffusion of soluble
molecules (Nagai et al., 2006; Censi et al., 2012; Koutsopoulos and
Zhang, 2012). The incorporation and release process is dictated by
the characteristics of the hydrogel such as the size of porous and
the molecular properties such as the monomer’s molecular weight
and its electrical charge (Nagai et al., 2006; Censi et al., 2012). In
the case where the porous size is bigger than the molecule, the
release occurs by diffusion (Amsden, 1998). On the other hand,
when the molecule is larger than the porous, degradation, swelling
and erosion of hydrogel permit the delivery of the molecule (Censi
et al., 2012).
Administration of drugs is a necessity in the treatment of
many injuries and diseases; however, commonly these drugs
inside the body are metabolized and therefore have a limited time
window to exert their actions. A local and controlled delivery of
drugs could improve the treatments of many diseases or injuries,
especially those that occur in the CNS. The delivery of drugs
in the CNS implies a great challenge because the presence of
BBB and the blood–spinal cord barrier, that impede the passage
of many substances to the CNS (Pakulska et al., 2012). Some
current delivery drugs methods into the CNS are bolus injection
and catheter/minipump systems (Pakulska et al., 2012). Bolus
injection into the intrathecal space is affected by the constant flow
of cerebrospinal liquid, which disperse the drug, reducing its local
effect (Pakulska et al., 2012). On the other hand, the use of a
catheter/minipump system has high infection probabilities, due to
the external minipump location. Furthermore, it is frequent that
catheters suffer dislodgement, kinking, tearing and disconnection
(Penn et al., 1995).
Because of the in situ gelling process, it is possible to
use hydrogels as a local delivery system (Censi et al., 2012;
Koutsopoulos and Zhang, 2012; Macaya and Spector, 2012;
Pakulska et al., 2012), although it will be necessary to find out the
best alternative to introduce the hydrogel into the brain or another
site of the NS. It is feasible to put the hydrogel in a damaged
area and release molecules there, allowing the local delivery of
a drug, which could enhance the effectiveness of treatment. In
addition, the use of biodegradable hydrogels is especially relevant
for long-term treatments, since it will prevent repetitive invasive
interventions. The data demonstrate that hydrogels are a very
versatile release system because is possible to manipulate the
rate of delivery and the rate of degradation. Hydrogels could be
modified to release some medicament depending on the specific
circumstances, like the half-life of the medicament, the dosage or
the time that is required for treatment.
HYDROGELS PROMOTE AXONAL REGENERATION
Hydrogels present characteristics that make them good candidates
to fulfill the needs required to promote axonal regeneration after
lesions of the CNS, such as filling up the cavity of a lesion with a
suitable substrate (Figure 1B). Although the PNS environment is
less restrictive for axonal growth, as described previously, there are
many challenges to achieve a successful regeneration. It is essential
to reduce the probability of mismatches by providing guidance
cues for correct reinnervation, and hydrogels can help to attain
this task (Figure 2B). However, a note of caution is appropriate
because, in addition to act as scaffold and delivery tools, hydrogels
might represent a physical barrier for both cellular and axonal
reorganization. In this section we review the published evidence
showing that hydrogels promote axonal regeneration both in vitro
and in vivo.
IN VITRO STUDIES
Hydrogels properties such as its high water content, their porous
constitution and the three dimensional (3D) networks formed
during gelling, mimic to some extent the ECM found in tissues
(Geckil et al., 2011; Aurand et al., 2012; Kirschner and Anseth,
2013), making possible to culture cells in 3D structures in vitro.
These structures are closer to the in vivo environment than the
classic two-dimensional cultures (Zhang et al., 2005b).
Early work (Holmes et al., 2000) aimed to obtain self-
assembling peptides with motifs similar to the arginine-glycine-
aspartate (RGD) present in several ECM proteins. The authors
substituted glycine with alanine (A) and repeated the RADA
sequence several times. To assess the suitability of this self-
assembling peptide hydrogel, a direct comparison with Matrigel
(a commercial substrate containing ECM derived from carcinoma
cells) was made after culturing rat hippocampal neurons. No
differences in synaptic activity measured by the endocytosis
marker FM1-43 were found, showing that this hydrogel
can support neuronal maturation. Recently, RADA-containing
peptides were used to form 3D structures to allocate neural
stem progenitor cells (NSPC) in order to evaluate proliferation
and neuronal differentiation (Koutsopoulos and Zhang, 2013).
Both Matrigel and the self-assembled peptide-based hydrogels
sustained these parameters. Matrigel was efficient during the
first 2 weeks, but the hydrogel allowed neuronal survival for
over 5 months. These data demonstrate that hydrogels support
neuronal differentiation and long-term survival with signs of
maturity.
In another study, using dopaminergic cells, Semaphorin
3A was coupled to a PEG hydrogel containing silica particles
to assess the effects on axonal growth. Semaphorin 3A is a
soluble protein implicated in the axonal growth of dopaminergic
neurons during brain development (Hernández-Montiel et al.,
2008). Application of recombinant Semaphorin 3A to these
dopaminergic neurons obtained from the developing midbrain or
from in vitro differentiated mouse embryonic stem cells caused
increased growth of axons in a collagen gel system in culture. This
effect was neutralized by anti-Neuropilin receptors (Tamariz et al.,
2010). A significant increase in axonal length was observed with
the PEG hydrogel containing either 2 or 5 µg/ml Semaphorin
3A compared to controls (Tamariz et al., 2011). Recently, a
PEG hydrogel device was designed to evaluate the influence
of distance in the application of a potential axonal growth-
promoting molecule on murine embryonic stem cell-derived
neurons. These authors conjugated Insulin-like Growth Factor 1
to poly-lactic-co-glycolic acid particles with several admixtures
that resulted in different release kinetics: early, intermediate
and late. The optimal conditions were: (i) a distance up to
2 mm between the poly-lactic-co-glycolic acid particles and
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neurons; (ii) a sequential array of early, intermediate and late
release conjugates; (iii) the early release particles placed closer
to the cells and those with late kinetics placed away (Lee et al.,
2014).
An intermediate step between two-dimensional in vitro
cultures and in vivo studies is the culture of organotypic slices,
because they maintain the ECM and the 3D organization. In
cultured spinal cord slices placed on different substrates such
as membrane inserts, Collagen gel, soluble hyaluronic acid
and hyaluronic acid-based hydrogel, different cell-type specific
markers were analyzed. The hydrogel group preserved better than
the other groups the characteristics of the slice: more neurons
(NeuN+), a greater proportion of choline acetyltransferase-
positive neurons, well-preserved astroglia and less number of
activated microglial cells were reported (Schizas et al., 2014).
The data of these works confirmed that hydrogels could be
used as a delivery system to promote axonal growth, and
preserve better the organotypic cultures. These characteristics
might be useful to promote a successful axonal regeneration
in vivo.
IN VIVO STUDIES
Hydrogels as a strategy for promoting regeneration in the brain
Several groups have assessed the biocompatibility of hydrogels
in the absence of a lesion. PEG hydrogels with 13% and
20% macromer weight, and 20% PEG conjugated with GDNF
were implanted into the cortex and striatum of nonhuman
primates. Four months after implantation the astroglial and
microglial reactions were present around the implant site of
all groups, including sham. The 13% PEG hydrogel generated
fewer reactions, probably due to its faster degradation (Bjugstad
et al., 2008). This same group evaluated the biocompatibility of
different weight percent of PEG hydrogel implanted as strands
across the rat brain. The analysis in striatum revealed that both
13% and 20% hydrogels attenuate the acute response of reactive
glia, compared to the sham group after 56 days (Bjugstad et al.,
2010). However, when PEG was conjugated with silica particles
and implanted into striatum, a higher amount of macrophages
and glial cells were founded around the injection site after 30
days, compared to controls. The authors correlated this enhanced
glial reaction with the presence of silica particles that were not
degraded (Tamariz et al., 2011).
In some cases, one important limitation for axonal
regeneration is the presence of a cavity in the damaged tissue
(Figure 1A). Hydrogels have been proved to be able to fill such
cavity and promote axonal growth (Figure 1B). After resection
of a fraction of the cerebral cortex, the resulting cavity was filled
with a hydrogel based on self-assembling peptides or with saline
solution. After 6 weeks the hydrogel significantly reduced the
lesion volume, and cellular ingrowth was detected. A significant
decrease in astrocytic cells and macrophages was observed in the
first 2 weeks, compared to the saline group (Guo et al., 2009).
Hou et al. also caused a cortical damage in rats, but they used
hyaluronic acid-based hydrogel, either alone or modified to
incorporate Laminin in its structure, to fill the cavity. After six
and twelve weeks hydrogels allow cell infiltration, angiogenesis
and inhibition of the glial scar; however, only the hydrogel
with Laminin was permissive for neurite growth (Hou et al.,
2005).
One of the first attempts to evaluate the implantation of
hydrogels together with living cells in the brain was made by
Woerly et al. (1996). In this study SC, neonatal astrocytes or
cells dissociated from embryonic cerebral hemispheres were
entrapped in (N-(2-hydroxypropyl)-methacrylamide)-based
hydrogel. Hydrogels containing SC were implanted into the
rat neocortex, and promoted cellular and axonal ingrowth
within the polymer. In another study, NSPC were encapsulated
into self-assembling peptide hydrogels modified to include the
IKVAV motif derived from Laminin (Cheng et al., 2013). Such
cell-containing hydrogels were used to fill the cavity caused by a
mechanical lesion in the neocortex of rats. Hydrogels made with
the IKVAV motif and NSPC promoted better tissue regeneration
and presented neurogenesis, compared to hydrogels without
the motif, which promoted modest tissue regeneration and
had prevalent glial differentiation. This study is in agreement
with previous data (Hou et al., 2005) that demonstrate that the
Laminin or Laminin-derived motif incorporated to hydrogel
structure allow the recovery of tissue continuity. Another group
tried to promote tissue recovery with a different strategy, which
consisted in incorporating GDNF to gelatin-based hydrogels,
with the objective to attract to the site of lesion the endogenous
NSPC present in the adult subventricular zone. The hydrogel
loaded with GDNF attenuated the astroglial reaction, promoted
neurite growth into the site of lesion and induced the migration
of neuroblasts towards the lesion site. However, cells did not
reach the site of lesion, and the migration effect was observed
only at 7 days post-lesion, disappearing after 21 days (Fon et al.,
2014).
Probably the most important aspect in the CNS is to achieve
re-connection of damaged areas, which in the long run might
positively impact behavior. In a model where hamsters’ optic
tracts were severed and the resulting cavity was filled with a self-
assembling peptide hydrogel or with saline solution, researchers
observed that the hydrogel helped to reconnect the areas around
the lesion after 6 weeks, in contrast to saline-treated animals.
More importantly, vision was improved in the hydrogel-treated
group (Ellis-Behnke et al., 2006). Although the degree of axonal
re-growth varies depending on the strategy used, hydrogels
have been demonstrated to be able to fill the lesion cavity
with a suitable substrate for axonal growth, and the further
addition of trophic factors or cells increases the possibilities of
improvement after traumatic lesions in the brain (Figure 1B).
However, in general terms, the evidence is still insufficient to
say that hydrogels would substitute current treatments for brain
lesions.
Hydrogels promote regeneration in the spinal cord
The studies showing that hydrogels promote axonal growth in
vitro prompted investigators to test if implantation of hydrogels
into the damaged spinal cord could promote recovery. A
hyaluronic acid hydrogel was evaluated in vitro and in vivo to
investigate if it was able to promote neurite growth. Although this
hydrogel promoted neurite growth in vitro, it was not sufficient to
achieve functional recovery when implanted in rats with complete
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transected thoracic spinal cord (Horn et al., 2007). Transection
of the spinal cord in cats followed by filling of the cavity
with NeuroGel hydrogel (N-(2-hydroxypropyl) methacrylamide)
permitted the formation of neural tissue with myelinated axons
across the damaged area, connecting both sides of the cavity, and
allowing infiltration of glial cells and capillary vessels (Woerly
et al., 2001). In additional work, the authors found that the
hydrogel prevented scar formation and that the gliosis reaction
was reduced in the interface between tissue and hydrogel (Woerly
et al., 2004).
One possibility in the design of a suitable scaffold is the
combination of two different types of hydrogels, to obtain a
better substrate. A combined poly lactic acid (PLA) and poly
(2-hydroxyethyl methacrylate, PHEMA) hydrogel was devised to
obtain a degradable porous structure. This mixed hydrogel was
implanted in the hemisected spinal cord of rats and demonstrated
to promote axonal growth into the lesion area; moreover, animals
improved in the widely used behavioral Basso, Beattie and
Bresnahan scale (Pertici et al., 2014). Another strategy evaluated
to bridge the two stumps after a spinal cord lesion is the
use of tubular structures, which provide mechanical support
for axonal regeneration. A tubular device made with poly
(2-hydroxyethyl methacrylate-co-methyl methacrylate, PHEMA-
MMA) hydrogel was used to join the transected spinal cord
of rats and this strategy resulted in the re-establishment of
tissue continuity, allowing axon regeneration with minimal
scar tissue. Although the empty tubular structure promoted
recovery by itself, it was proposed that filling the tubular
structure with a suitable substrate could be a better option to
promote recovery (Tsai et al., 2004). The same group evaluated
this approach (Tsai et al., 2006), filling the tubular structure
used previously with matrices of Collagen, Fibrin, Matrigel,
methylcellulose or smaller PHEMA-MMA tubes. In addition,
Fibrin and Collagen were supplemented with Fibroblast growth
factor-1 (FGF-1) and NT-3. It was observed that almost all the
matrices used promoted more axonal regeneration compared to
unfilled structures. The addition of FGF-1 increased the axonal
regeneration of vestibular neurons, and the addition of NT-3
decreased the total number of axons regenerating from brainstem
neurons.
In addition to promote axonal regeneration, hydrogels can
incorporate into its structure trophic factors and release them
on site after a spinal cord lesion. PHEMA hydrogels soaked
with BDNF and control PHEMA hydrogels were implanted
into the hemisected spinal cords of rats. Only the BDNF-
containing hydrogel allowed axonal growth into the polymer
structure (Bakshi et al., 2004). Similarly, BDNF was embedded
into agarose hydrogel and implanted into hemisected spinal cords
of rats. It was demonstrated that it promoted greater axonal
growth in contrast to hydrogels without BDNF (Jain et al.,
2006). Another trophic factor evaluated in spinal cord lesions
is NT-3, which was combined to a hydrogel of acrylated PLA-
b-PEG-b-PLA to release it in hemisected cord of rats. Animals
treated with hydrogel and NT-3 presented more axonal growth
into the lesion site and improved in the behavioral parameters,
in contrast to animals treated only with hydrogel (Piantino
et al., 2006). Collectively, these experiments strongly suggest that
incorporation of molecules that promote axonal growth and/or
cell survival increases the possibilities of recuperation after a
spinal cord lesion.
As mentioned earlier, hydrogels can incorporate living cells,
making grafting of cells together with hydrogel an additional
strategy to promote recovery. SC and NSPC have been implanted
with and self-assembling peptide-based hydrogel into transected
spinal cord of rats. The ingrowth of tissue to the lesion was
better in animals treated with hydrogel-embedded cells than those
treated with hydrogel alone. NSPC and SC can survive, migrate,
and differentiate into the site of lesion, with SC promoting greater
axonal growth into damaged area (Guo et al., 2007). Another
study demonstrated that when the same hydrogel was implanted
with SC in a moderate spinal cord contusion model in rats, there
was a reduction of astrogliosis reaction, a motor recovery and
infiltration of endogenous SC to the lesion site was observed
(Moradi et al., 2012).
Hydrogels promote regeneration in the PNS
Although the PNS allows some degree of regeneration,
mismatches are frequent and limit its recovery. The best
strategy to promote axonal regeneration in peripheral nerve
injuries is the use of autografts, but this convey some problems
such as donor tissue morbidity and loss of function in the
tissue innervated by donor nerve (Schlosshauer et al., 2006).
Some attempts have been made to substitute the autografts
with variable results. Hydrogel porous tubes constructed with
PHEMA-MMA were implanted into interrupted sciatic nerves.
At early times the autografts were more effective as evaluated
by histomorphology and electrophysiology. However, after 8
weeks the scaffold showed a bimodal recovery: 60% of animals
surpassed the autografts but rest did not, probably due to tube
collapse (Belkas et al., 2005). A more rigid hybrid conduit was
designed with poly (3,4-ethylenedioxythiophene, PEDOT) and
agarose hydrogel. This device was implanted in 10 mm peroneal
nerve gaps and the regeneration was evaluated by muscle mass,
contractile force measurements and nerve histomorphometry.
The hybrid conduits promoted better regeneration compared
to agarose-only hydrogel, but autografts presented much better
results (Abidian et al., 2012).
Filling of conduits with a substrate, which allows axonal
growth, could enhance the regenerative process (Figure 2B).
An empty blood vessel filled with a self-assembling peptide
hydrogel, implanted in a sciatic nerve gap of 10 mm, promoted
higher numbers of growing and re-myelinated axons, more
SC infiltration, less presence of lymphocytes and macrophages,
greater gastrocnemius muscle recovery and better behavioral
improvement, compared to empty conduits. However, the
recovery was not comparable in retrograde labeling and
electrophysiology, to unlesioned animals (Zhan et al., 2013).
Another group developed a Keratin-based hydrogel to fill
commercial tubular conduits, which improved histological
characteristics such as number of blood vessels, axons per area,
and axon size. Furthermore, electrophysiological features such as
conduction delay and impulse amplitude were better than with
the empty tubular structures, and comparable to autografts. These
results were obtained in mice with a 4 mm gap in the tibial nerve
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(Sierpinski et al., 2008) and in rabbits with a 2–3 cm sciatic
nerve break (Hill et al., 2011). The same group characterized
the early cellular response after implantation of a commercial
tubular structure filled with Keratin-based hydrogel, Matrigel or
saline solution in rats presenting a 1 cm sciatic nerve injury.
Significant differences present in the hydrogel group compared to
others were: an earlier migration of dedifferentiated endogenous
SC from the proximal end, faster SC dedifferentiation, higher
myelin debris clearance, and decreased macrophage infiltration.
However, others parameters, such as axon density, SC labeling
or the amount of cells in the distal nerve did not present
differences (Pace et al., 2013). It is worth mentioning that
this is the only study in which the cellular response was
characterized post-hydrogel implantation after peripheral nerve
injury.
The release of molecules in situ after a lesion could enhance
axonal growth through the lesion, contributing to reinnervation
of correct areas (Macaya and Spector, 2012), increasing the
possibilities of recovery (Figure 2B). Animals suffering from a
10 mm gap in the sciatic nerve were implanted with PHEMA-
MMA hydrogel porous tubes, filled with Collagen matrices
supplemented with NT-3, BDNF and FGF-1. The rats treated with
growth factors presented better axonal regeneration compared
to animals receiving empty tubes, or Collagen without factors.
Tubes filled with collagen and 10 µg/ml FGF-1 presented similar
number of fibers with diameters similar to animals that received
autografts (Midha et al., 2003). Similarly, polysulfone tubes filled
with agarose hydrogel containing Laminin-1 and NGF, implanted
in the severed sciatic nerve caused equivalent recovery to animals
that received autografts in parameters such as morphology of
the regenerated nerve and the density of myelinated axons.
However, although the functional recoveries of sciatic nerve were
similar after hydrogel or autograft treatment, these values were
significantly lower than the non-lesioned condition (Yu and
Bellamkonda, 2003).
Ultrafiltration membrane conduits filled with a self-
assembling peptide hydrogel containing SC were implanted
into the damaged sciatic nerve. This device caused better axonal
growth and linear alignment of nerve fibers with SC than
conduits filled with: (a) self-assembling peptide-only hydrogel;
(b) alginate/Fibronectin hydrogel or (c) alginate/Fibronectin with
SC. (McGrath et al., 2010). These studies demonstrated that the
combination of a tubular structure, which provides mechanical
support, filled with hydrogels increases the possibilities of axonal
regeneration after peripheral nerve injury. In addition, this
system could be improved by the addition of trophic factors or
cells (Figure 2B). The reported recoveries are to some extent
similar to those resulting from autografts, the current gold
standard to treat peripheral nerve damage. However, further
studies that evaluate the recovery with additional parameters,
such as electrophysiological studies and anterograde/retrograde
labeling through regenerated axons across the damaged area are
still needed.
CONCLUSION
Increasing the possibilities for axonal regeneration after neuronal
damage is a complex challenge, because it is necessary to
overcome several limitations, which might imply different
strategies. Hydrogels have demonstrated to be useful to overcome
some of these barriers, particularly by providing an adequate
substrate for axonal growth. Their versatility allows modification
of important parameters, which can positively impact on axonal
regeneration, and this is a significant advantage compared
to other biomaterials. Although different strategies such as
implantation of hydrogel, alone or combined with trophic factors
or with cells, have proved to promote axonal regeneration in
different animal models, more research is needed to determine
if hydrogels can be applied in the clinical setting in the
future. Tissue regeneration seems to consistently occur after
hydrogel application, but other parameters, particularly the
electrophysiological and behavioral tests show more variable
results, and these shortcomings will hopefully be resolved
soon.
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